Dihexa
CognitiveSmall Molecule / NeuroExperimental
Angiotensin-IV–derived peptidomimetic studied preclinically for synaptogenic/neurotrophic signaling (research-only).
For research use only.
Key Facts
- CAS
- 1401708-83-5
- Molecular Weight (MW)
- 504.70 g/mol
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- —
- Last updated
- 12/14/2025
Overview
Angiotensin-IV–derived peptidomimetic studied preclinically for synaptogenic/neurotrophic signaling (research-only).
Protocol
- Dosage Range
- —
- Frequency
- —
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
Science
Mechanism of Action
Putative HGF/c-Met pathway modulator; investigated for cognitive support (preclinical).
Studies are being curated for this entry.
Suggest a studyBenefits
Cognitive support (preclinical)Neuroprotection (preclinical)
Potential Side Effects
- Potential adverse effects depend on compound, dose, purity, and route; consult clinician.